| Product Name | MF | CAS | Details |
|---|
| 3-Oxo-4-aza-5a-a-ndrost-1-ene-17b-carboxylic acid methyl ester | C20H29NO3 | 103335-41-7 | Details |
| N-Benzylcyclohexanamine | C13H19N | 4383-25-9 | Details |
| (4,6-Dichloropyridin-2-yl)methanamine hydrochloride | C6H7Cl3N2 | 1956369-49-5 | Details |
| S3 12 antibody | Details |
| 4-Isopropylphenylacetic acid | C11H14O2 | 4476-28-2 | Details |
| 2,6-Dichloropyridine-3-carboxylic acid | C6H3Cl2NO2 | 38496-18-3 | Details |
| N-Methyl-L-glutamic acid | C6H11NO4 | 6753-62-4 | Details |
| 5,7-Diacetoxy-3,4',8-trimethoxyflavone | C22H20O9 | 5128-43-8 | Details |
| tert-Butyl N-(but-3-en-1-yl)-N-methylcarbamate | C10H19NO2 | 312728-28-2 | Details |
| Lithium 1,3-dimethyl-2-oxopyrrolidine-3-carboxylate | C7H10LiNO3 | 2031259-32-0 | Details |
| Meloxicam - Bio-X ? | C14H13N3O4S2 | 71125-38-7 | Details |
| tert-Butyl 3-(Hydrazinocarbonyl)piperidine-1-carboxylate | C11H21N3O3 | 859154-32-8 | Details |
| 1-(2-Bromo-4-methylphenyl)cyclohexan-1-amine hydrochloride | 1909308-98-0 | Details |
| (R)-Octahydro-1H-pyrido[1,2-a]pyrazine dihydrochloride ee | C8H16N2.2ClH | 634922-12-6 | Details |
| 2-Bromo-5-fluoro-4-nitroaniline | C6H4BrFN2O2 | 952664-69-6 | Details |
| Kaempferol-3-rutinoside-7-rhamnoside | C33H40O19 | 57526-56-4 | Details |
| (2S,3aS,6aS)-1-[(tert-Butoxy)carbonyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid | C13H21NO4 | 124002-32-0 | Details |
| UNC45A Blocking Peptide | Details |
| 4-(tert-Butoxycarbonylamino)-3-methylisothiazole-5-carboxylic acid | C10H14N2O4S | 876191-57-0 | Details |
| 2-Cyclobutyl-1-phenylethan-1-amine | C12H17N | 1432681-33-8 | Details |
| Boc-Arg-Val-Arg-Arg-AMC acetate salt | C38H62N14O8 | 136132-77-9 | Details |
| 2-(1-Aminocyclopropyl)acetic acid hydrochloride | C5H10ClNO2 | 139132-50-6 | Details |
| PMEL antibody | Details |
| Lysozyme - Enzyme activity min 70000 FIP/mg | C125H196N40O36S2 | 12650-88-3 | Details |
| 1-[4-(Trifluoromethyl)phenyl]-1H-pyrazol-4-amine | C10H8F3N3 | 1251264-73-9 | Details |
| 3-Ethyl-3,9-diazabicyclo[4.2.1]nonane | C9H18N2 | 1376047-26-5 | Details |
| 5-Oxaspiro[2.5]octane-1-carboxylic acid | C8H12O3 | 1341939-27-2 | Details |
| Uroguanylin Topoisomer A (human) trifluoroacetate salt | C64H102N18O26S4 | 154525-25-4 | Details |
| 3-(4-Bromophenyl)oxetan-3-ol | C9H9BrO2 | 1093878-32-0 | Details |
| Euphorbia factor L9 | C37H41NO9 | 129393-28-8 | Details |
| 2-Bromo-6,7-dihydrobenzo[D]thiazol-4(5H)-one | C7H6BrNOS | 1280703-98-1 | Details |
| 8-Methoxyquinolin-2-amine | C10H10N2O | 104090-86-0 | Details |
| 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenol | C12H20O2Si | 80180-46-7 | Details |
| 3-Cyclopentyl-[1,2]oxazolo[5,4-b]pyridine-5-carboxylic acid | C12H12N2O3 | 1334148-01-4 | Details |
| N-(1-Amino-2-methylpropan-2-yl)methanesulfonamide hydrochloride | C5H15ClN2O2S | 1311315-72-6 | Details |
| Na+ Ca2+ Exchanger antibody | Details |
| 4-Phenyl-1,3-oxazole-2-thiol | C9H7NOS | 17371-97-0 | Details |
| N-(Triphenylmethyl)-D-asparagine monohydrate | C23H24N2O4 | 1998701-21-5 | Details |
| 3-(2-Chloroethanesulfonyl)propanamide | C5H10ClNO3S | 1562-40-9 | Details |
| Nad 299 hydrochloride | C18H24ClFN2O2 | 184674-99-5 | Details |
| 9H-Fluoren-9-ylmethyl N-(2-hydroxypropyl)carbamate | C18H19NO3 | 185308-00-3 | Details |
| 2-(Prop-2-en-1-yl)cyclopentan-1-one | C8H12O | 30079-93-7 | Details |
| SPERT antibody | Details |
| 3-Nitro-1,2-phenylenediamine | C6H7N3O2 | 3694-52-8 | Details |
| Decorsin | Details |
| (3-Fluorophenyl)(3-methylphenyl)methanone | C14H11FO | 864087-22-9 | Details |
| Delamanid | C25H25F3N4O6 | 681492-22-8 | Details |
| Ethyl 2-(cyclopent-2-en-1-yl)acetate | C9H14O2 | 15848-49-4 | Details |
| 2-(((5-bromo-3-methyl-2-pyridyl)amino)methyl)phenol | C13H13BrN2O | 306732-30-9 | Details |
| 3,5-Dichloro-N-(2-methyl-3-oxobutan-2-yl)benzamide | C12H13Cl2NO2 | 29918-41-0 | Details |
| 4-(Cyclopropylmethoxy)-2-fluoroaniline | C10H12FNO | 1236764-17-2 | Details |
| 2-(3,5-Dichlorophenyl)prop-2-enenitrile | C9H5Cl2N | 1803584-20-4 | Details |
| UBE3B antibody | Details |
| {4H,6H,7H-Pyrano[4,3-d][1,3]thiazol-2-yl}methanamine | C7H10N2OS | 1157010-23-5 | Details |
| 1-(3-Chloro-4-hydroxyphenyl)propan-1-one | C9H9ClO2 | 2892-27-5 | Details |
| (S)-(+)-Citramalic acid | C5H8O5 | 6236-09-5 | Details |
| {[4-Methoxy-3-(morpholin-4-ylmethyl)phenyl]methyl}(methyl)amine | C14H22N2O2 | 893732-53-1 | Details |
| Ethyl 4-cyclopropyl-1H-pyrrole-3-carboxylate | C10H13NO2 | 936720-85-3 | Details |
| N-Methyltaurine sodium, 60% aqueous solution | C3H10NNaO3S | 4316-74-9 | Details |
| 2S,4S)-4-Fluoropyrrolidin-2-Yl)Methanol Hydrochloride | C5H11ClFNO | 623583-08-4 | Details |
| 4-Chloro-6-(4-ethylpiperazin-1-yl)pyrimidine | C10H15ClN4 | 1247461-83-1 | Details |
| H-SGR-OH | Details |
| (4-Methoxynaphthalen-2-yl)methanamine hydrochloride | C12H14ClNO | 1864073-43-7 | Details |
| TBCA protein | Details |
| Duligotuzumab | 1314238-96-4 | Details |
| 4-Bromo-3-chlorobenzene-1,2-diamine | C6H6BrClN2 | 1008361-80-5 | Details |
| 5-(4-Chlorophenoxymethyl)furan-2-carbaldehyde | C12H9ClO3 | 438219-08-0 | Details |
| 2-(((4-(tert-butyl)phenyl)sulfonyl)amino)benzamide | C17H20N2O3S | 680591-19-9 | Details |
| BW373U86 dihydrobromide | C27H38BrN3O2 | 1174661-92-7 | Details |
| 2-{[(4-Benzylmorpholin-2-yl)methyl](methyl)amino}acetamide | C15H23N3O2 | 1803583-49-4 | Details |
| 1-Methanesulfonylcyclobutane-1-carbonitrile | C6H9NO2S | 1248918-52-6 | Details |
| [1-(4-Fluorophenyl)-2-methylpropyl](methyl)amine | C11H16FN | 1157105-87-7 | Details |
| CDR2L Blocking Peptide | Details |
| N-Benzyl-2-fluoroaniline hydrochloride | C13H13ClFN | 1987680-56-7 | Details |
| 2-tert-Butyl-1,3-thiazole-4-carbaldehyde | C8H11NOS | 937663-81-5 | Details |
| 3,3-Difluoro-2,2-dimethyl-propan-1-ol | C5H10F2O | 2098097-57-3 | Details |
| Ipsenol | C10H18O | 14314-21-7 | Details |
| [4-(4-Chlorophenoxy)phenyl]boronic acid | C12H10BClO3 | 1035491-05-4 | Details |
| Bromoacetamido-dPEG?24-TFP Ester | Details |
| 5-Hydrazinyl-2-phenyl-1,3-oxazole-4-carbonitrile | C10H8N4O | 314748-14-6 | Details |
| Enniatin B | C33H57N3O9 | 917-13-5 | Details |
| 2-(4-Fluorophenoxymethyl)pyrrolidine | C11H14FNO | 883541-89-7 | Details |
| H-SEQLGGDVESYDK^-OH | Details |
| (2R,4S)-1-Acetyl-4-methoxypyrrolidine-2-carboxylic acid | C8H13NO4 | 1807885-24-0 | Details |
| (2R)-2-[({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)oxy]propanoic acid | 2248197-89-7 | Details |
| 6-(Propane-2-sulfonamido)pyridine-3-carboxylic acid | C9H12N2O4S | 1249354-43-5 | Details |
| H-GGVPMSMRGGGK-OH | Details |
| 4-(Cyclopentyloxy)cyclohexan-1-one | C11H18O2 | 1566478-08-7 | Details |
| H-AVGALEGPRNQDWLGVPRQL-OH | Details |
| 6-Bromoquinazolin-4-amine | C8H6BrN3 | 21419-48-7 | Details |
| 5-(Methylaminomethyl)-2-thiouridine | C11H17N3O5S | 32860-54-1 | Details |
| 1-Chloro-3-(chloromethoxy)benzene | C7H6Cl2O | 35657-03-5 | Details |
| GLA Blocking Peptide | Details |
| Vitamin D Total, NH2 Conjugate | Details |
| RFA2 antibody | Details |
| N1,N8-Diacetylspermidine | C11H23N3O2 | 82414-35-5 | Details |
| 1-Fluoro-3-(methylsulfanyl)-2-nitrobenzene | C7H6FNO2S | 305811-06-7 | Details |
| TJP2 Blocking Peptide | Details |
| N-Butyl-N-methyl-2-sulfanylacetamide | C7H15NOS | 140712-52-3 | Details |
| 6-Silaspiro[5.5]undecan-3-amine hydrochloride | C10H22ClNSi | 1330166-70-5 | Details |
| Product Total： Product Page： | ||||
| 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 | ||||